EASL Clinical Practice Guidelines. Drug-induced liver injury. J Hepatol. 2019;70(6):1222–1261. https://doi.org/10.1016/j.jhep.2019.02.014. Epub 2019 Mar 27 PMID: 30926241

Article  Google Scholar 

Bessone F, Robles-Diaz M, Hernandez N, Medina-Caliz I, Lucena MI, Andrade RJ. Assessment of serious acute and chronic idiosyncratic drug-induced liver injury in clinical practice. Sem Liver Dis. 2019;39(03):381–94

Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J, Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008;135(6):1924–34, 1934.e1-4. https://doi.org/10.1053/j.gastro.2008.09.011. Epub 2008 Sep 17. PMID: 18955056; PMCID: PMC3654244

Fontana RJ, Hayashi PH, Gu J, Reddy KR, Barnhart H, Watkins PB, Serrano J, Lee WM, Chalasani N, Stolz A, Davern T, Talwakar JA, DILIN Network. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset. Gastroenterology. 2014;147(1):96–108.e4. https://doi.org/10.1053/j.gastro.2014.03.045. Epub 2014 Mar 27. PMID: 24681128; PMCID: PMC4285559

Medina-Caliz I, Robles-Diaz M, Garcia-Muñoz B, Stephens C, Ortega-Alonso A, Garcia-Cortes M, González-Jimenez A, Sanabria-Cabrera JA, Moreno I, Fernandez MC, Romero-Gomez M, Navarro JM, Barriocanal AM, Montane E, Hallal H, Blanco S, Soriano G, Roman EM, Gómez-Dominguez E, Castiella A, Zapata EM, Jimenez-Perez M, Moreno JM, Aldea-Perona A, Hernández-Guerra M, Prieto M, Zoubek ME, Kaplowitz N, Lucena MI, Andrade RJ, Spanish DILI Registry. Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury. J Hepatol. 2016;65(3):532–42. https://doi.org/10.1016/j.jhep.2016.05.003. Epub 2016 May 13. PMID: 27184533; PMCID: PMC7458366

Corsini A, Bortolini M. Drug-induced liver injury: the role of drug metabolism and transport. J Clin Pharmacol. 2013;53(5):463–474. https://doi.org/10.1002/jcph.23. Epub 2013 Feb 22 PMID: 23436293

Article  CAS  PubMed  Google Scholar 

Kubitz R, Dröge C, Stindt J, Weissenberger K, Häussinger D. The bile salt export pump (BSEP) in health and disease. Clin Res Hepatol Gastroenterol. 2012;36(6):536–553. https://doi.org/10.1016/j.clinre.2012.06.006. Epub 2012 Jul 12 PMID: 22795478

Article  CAS  PubMed  Google Scholar 

de Lima Toccafondo Vieira M, Tagliati CA. Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools. Expert Opin Drug Metabolism Toxicol. 2014;10(4):581–97. https://doi.org/10.1517/17425255.2014.884069

Lang C, Meier Y, Stieger B, Beuers U, Lang T, Kerb R, et al. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics. 2007;17(1):47–60. https://doi.org/10.1097/01.fpc.0000230418.28091.76. PMID: 17264802

Article  CAS  PubMed  Google Scholar 

Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, et al. Drug-induced liver injury network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32:55–68

CAS  PubMed  PubMed Central  Google Scholar 

Bénichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol. 1990;11(2):272–6. https://doi.org/10.1016/0168-8278(90)90124-a. PMID: 2254635

Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89(6):806–815. https://doi.org/10.1038/clpt.2011.58. Epub 2011 May 4 PMID: 21544079

Article  CAS  PubMed  Google Scholar 

Andrade RJ, Lucena MI, Kaplowitz N, García-Muņoz B, Borraz Y, Pachkoria K, et al. Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry. Hepatology. 2006;44(6):1581–1588. https://doi.org/10.1002/hep.21424. PMID: 17133470

Article  CAS  PubMed  Google Scholar 

https://cioms.ch/wp-content/uploads/2020/06/CIOMS_DILI_Web_16Jun2020.pdf

Lewis JH. Causality assessment: which is best expert opinion or RUCAM? Clin Liver Dis (Hoboken). 2014;4(1):4–8. https://doi.org/10.1002/cld.365. PMID: 30992910; PMCID: PMC6448723

Article  PubMed  Google Scholar 

Srivastava A. Progressive familial intrahepatic cholestasis. J Clin Exp Hepatol. 2014;4(1):25–36. https://doi.org/10.1016/j.jceh.2013.10.005

Article  PubMed  Google Scholar 

Hoofnagle JH, Di Bisceglie AM. Serologic diagnosis of acute and chronic viral hepatitis. Semin Liver Dis. 1991;11(2):73–83. https://doi.org/10.1055/s-2008-1040426. PMID: 1909458

Article  CAS  PubMed  Google Scholar 

Aithal PG, Day CP. The natural history of histologically proved drug-induced liver disease. Gut. 1999;44(5):731–735. https://doi.org/10.1136/gut.44.5.731. PMID: 10205214; PMCID: PMC1727509

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Gao P, Niu J. Metabolic comorbidities and risk of development and severity of drug-induced liver injury. Biomed Res Int. 2019;18(2019):8764093. https://doi.org/10.1155/2019/8764093. PMID: 31531370; PMCID: PMC6720367

Article  Google Scholar 

Shashidhara AN, Patil A, Bihari C. Co-existing non-transfusion-dependent hemoglobinopathies cause greater clinical and pathological severity of the chronic liver disease. GastroHep. 2021;3:100–106. https://doi.org/10.1002/ygh2.445

Article  Google Scholar 

Lee NCW, Carella MA, Papa S, Bubici C. High expression of glycolytic genes in cirrhosis correlates with the risk of developing liver cancer. Front Cell Dev Biol. 2018;31(6):138. https://doi.org/10.3389/fcell.2018.00138. PMID: 30430110; PMCID: PMC6220322

Article  Google Scholar 

Wang Q, Huang A, Wang JB, Zou Z. Chronic drug-induced liver injury: updates and future challenges. Front Pharmacol. 2021;8(12): 627133. https://doi.org/10.3389/fphar.2021.627133. PMID: 33762948; PMCID: PMC7982586

Article  CAS  Google Scholar 

Andrade RJ, Aithal GP, de Boer YS, Liberal R, Gerbes A, Regev A, Terziroli Beretta-Piccoli B, Schramm C, Kleiner DE, De Martin E, Kullak-Ublick GA, Stirnimann G, Devarbhavi H, Vierling JM, Manns MP, Sebode M, Londoño MC, Avigan M, Robles-Diaz M, García-Cortes M, Atallah E, Heneghan M, Chalasani N, Trivedi PJ, Hayashi PH, Taubert R, Fontana RJ, Weber S, Oo YH, Zen Y, Licata A, Lucena MI, Mieli-Vergani G, Vergani D, Björnsson ES, IAIHG and EASL DHILI Consortium. Nomenclature, diagnosis, and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report. J Hepatol. 2023;79(3):853–66. https://doi.org/10.1016/j.jhep.2023.04.033. Epub 2023 May 8. PMID: 37164270; PMCID: PMC10735171

Ieiri I, Takane H, Hirota T, Otsubo K, Higuchi S. Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy. Expert Opin Drug Metab Toxicol. 2006;2(5):651–74

CAS  PubMed  Google Scholar 

Okushin K, Tsutsumi T, Enooku K, et al. The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease. J Gastroenterol. 2016;51(8):808–18

CAS  PubMed  Google Scholar 

Thakkar N, Slizgi JR, Brouwer KLR. Effect of liver disease on hepatic transporter expression and function. J Pharm Sci. 2017;106(9):2282–94. https://doi.org/10.1016/j.xphs.2017.04.053

Article  CAS  PubMed  PubMed Central  Google Scholar 

Christensen H, Hermann M. Immunological response as a source to variability in drug metabolism and transport. Front Pharmacol. 2012;3:8. https://doi.org/10.3389/fphar.2012.00008

Article  PubMed  PubMed Central  Google Scholar 

Shasthry SM, Rastogi A, Bihari C, Vijayaraghavan R, Arora V, Sharma MK, et al. Histological activity score on baseline liver biopsy can predict non-response to steroids in patients with severe alcoholic hepatitis. Virchows Arch. 2018;472(4):667–75. https://doi.org/10.1007/s00428-018-2330-4. Epub 2018 Mar 7 PMID: 29516163

Article  CAS  PubMed  Google Scholar 

Broekhoven AGC, Ostyn T, van Melkebeke L, Verspaget HW, van der Merwe S, Verbeek J, et al. Histological characteristics in patients admitted to the hospital with alcoholic hepatitis complicated by acute-on-chronic liver failure. Scand J Gastroenterol. 2024;59(5):577–583. https://doi.org/10.1080/00365521.2024.2309527. Epub 2024 Feb 2 PMID: 38306114

Article  PubMed  Google Scholar 

Lucena MI, Andrade RJ, Kaplowitz N, García-Cortes M, Fernández MC, Romero-Gomez M, Bruguera M, Hallal H, Robles-Diaz M, Rodriguez-González JF, Navarro JM, Salmeron J, Martinez-Odriozola P, Pérez-Alvarez R, Borraz Y, Hidalgo R, Spanish Group for the Study of Drug-Induced Liver Disease. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology. 2009;49(6):2001–9. https://doi.org/10.1002/hep.22895. PMID: 19475693

Björnsson ES. Epidemiology, predisposing factors, and outcomes of drug-induced liver injury. Clin Liver Dis 2020;24:1–10. https://doi.org/10.1016/j.cld.2019.08.002

Wang CY, Deng Y, Li P, Zheng S, Chen G, Zhou G, et al. Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: a large multicenter study. Hepatology. 2022;75(6):1373–1385. https://doi.org/10.1002/hep.32283. Epub 2022 Jan 6 PMID: 34919746

Article  CAS  PubMed  Google Scholar 

Ganie SM, Pramanik PKD. A comparative analysis of boosting algorithms for chronic liver disease prediction. Healthcare Analy. 2024;5:100313. ISSN 2772-4425

Njei B, Osta E, Njei N, et al. An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitis. Sci Rep. 2024;14:8589. https://doi.org/10.1038/s41598-024-59183-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moncada-Torres A, van Maaren MC, Hendriks MP, et al. Explainable machine learning can outperform Cox regression predictions and provide insights into breast cancer survival. Sci Rep. 2021;11:6968. https://doi.org/10.1038/s41598-021-86327-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Christodoulou E, Ma J, Collins GS, Steyerberg EW, Verbakel JY, Van Calster B. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. J Clin Epidemiol. 2019;110:12–22. https://doi.org/10.1016/j.jclinepi.2019.02.004. (Epub 2019 Feb 11 PMID: 30763612)

Article  PubMed  Google Scholar 

Fassan M, Mescoli C, Sbaraglia M, Guzzardo V, Russo FP, Fabris R, et al. Liver histopathology in COVID-19 patients: a mono-institutional series of liver biopsies and autopsy specimens. Pathol Res Pract. 2021;221: 153451

CAS  PubMed